Rock Springs Capital Management LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 71 filers reported holding XENON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$49,629,474
-8.2%
1,272,877
+1.4%
1.49%
+8.9%
Q1 2024$54,052,590
-6.5%
1,255,5770.0%1.37%
-3.7%
Q4 2023$57,831,877
+43.7%
1,255,577
+6.6%
1.42%
+32.1%
Q3 2023$40,240,548
-11.3%
1,178,0020.0%1.08%
-0.1%
Q2 2023$45,353,077
+7.6%
1,178,0020.0%1.08%
+7.3%
Q1 2023$42,160,692
-9.1%
1,178,002
+0.2%
1.01%
-9.8%
Q4 2022$46,356,747
+11.1%
1,175,672
+1.7%
1.12%
+3.4%
Q3 2022$41,730,000
+22.1%
1,155,961
+2.9%
1.08%
+8.3%
Q2 2022$34,180,000
+32.7%
1,123,604
+33.4%
1.00%
+53.5%
Q1 2022$25,755,000
+6.9%
842,498
+9.2%
0.65%
+16.3%
Q4 2021$24,098,000
+170.5%
771,367
+32.3%
0.56%
+197.9%
Q3 2021$8,910,000
-16.4%
583,100
+1.9%
0.19%
-11.4%
Q2 2021$10,660,000
+4.0%
572,5000.0%0.21%
-5.8%
Q1 2021$10,248,000
+29.4%
572,500
+11.2%
0.22%
+33.3%
Q4 2020$7,921,000
+38.7%
515,000
-0.1%
0.17%
+15.9%
Q3 2020$5,709,000
-11.7%
515,7110.0%0.14%
-18.1%
Q2 2020$6,467,000
+14.1%
515,711
+3.1%
0.18%
-24.4%
Q1 2020$5,670,000500,0000.23%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,754,266$107,388,8317.33%
Altium Capital Management LP 360,600$14,059,7945.74%
Affinity Asset Advisors, LLC 994,227$38,764,9114.47%
First Light Asset Management, LLC 1,306,260$50,931,0774.46%
Nan Fung Group Holdings Ltd 106,680$4,159,4534.44%
Ally Bridge Group (NY) LLC 169,369$6,603,6973.93%
TLS Advisors LLC 32,956$1,2853.22%
BRAIDWELL LP 2,560,573$99,836,7413.13%
Paradigm Biocapital Advisors LP 2,043,280$79,667,4873.05%
BRIDGER MANAGEMENT, LLC 146,800$5,723,7322.94%
View complete list of XENON PHARMACEUTICALS INC shareholders